Dr. Abraham Krepostman, MD

Dr. Krepostman practices at McLaren Central Michigan in Mount Pleasant, Michigan, part of McLaren Health Care.

Dr. Krepostman's NPI, 1285661546, was assigned on June 26, 2006. Dr. Krepostman holds Michigan license 4301054975.

Dr. Krepostman's primary practice is McLaren Central Michigan, at 1221 South Drive, Mount Pleasant, MI 48858 in Isabella County. The practice phone is (989) 772-6700.

Dr. Krepostman's primary practice is McLaren Central Michigan in Mount Pleasant, Michigan, part of McLaren Health Care. Dr. Krepostman is also affiliated with MyMichigan Medical Center Clare. The medical group on file is McLaren Central Michigan. Dmand AI also links Dr. Krepostman to 4 more hospitals and 2 medical groups, each named with a free account. Dr. Krepostman's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krepostman practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Krepostman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Krepostman is licensed in Michigan.

CMS data shows 1,521 Medicare services from Dr. Krepostman across 6 procedure codes in 2024, for 1,028 Medicare patients. Medicare paid $21,797 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,028 Medicare patients who saw Dr. Krepostman in 2024. The largest group is 65 to 74, with 355 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Krepostman's median patient age at 74, with 52% women.

In 2024, Dr. Krepostman wrote 6,954 Medicare Part D claims for 836 patients. 76% of them were for generic drugs. CMS names the drug for 6,495 of them, across 72 drugs with 11 or more claims each, at $1,822,647 in total drug cost. In 2023, CMS named 6,682 claims across 77 drugs.

Dr. Krepostman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 613 general payments to Dr. Krepostman from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,655.